This clinical trial is focused on studying early-stage, intermediate-risk cervical cancer. The treatment being investigated involves the use of Carboplatin and Cisplatin, which are medications given through an infusion into the vein. These medications are known as platinum-containing compounds and are commonly used in cancer treatment.
The purpose of the study is to determine if adding additional treatment with chemotherapy and radiation after surgery can help patients live longer without the cancer coming back. Participants in the study will be randomly assigned to one of two groups. One group will receive the additional treatment with chemotherapy and radiation after surgery, while the other group will not receive any further treatment after surgery. The study will follow participants over a period of time to see how well they do with each approach.
Throughout the study, participants will receive regular check-ups and monitoring to assess their health and the status of their cancer. The study aims to provide valuable information on the best treatment approach for patients with this type of cervical cancer, potentially improving outcomes and quality of life for those affected by the disease.



Austria
Belgium
Czechia
Italy
Poland
Spain